Our Mission
We catalyze and accelerate innovation in cancer data science, thus advancing cancer research and transforming cancer prevention and care.
We seek to increase capacity for data-driven cancer research and evidence-based cancer care, by creating a hub for Penn and CHOP data scientists who work in the field. READ MORE
Announcements/News
October 2023
2023 SEAS/PSOM Symposium on Trustworthy AI for Healthcare
June 2023
New NCI U01 on developing responsible AI tools to address data bias and disparities in cancer research
June 2023
Team Penn won the Honorable Mention in the NIH Long COVID Computational Challenge (L3C)
September 2022
The Pre-medical Cancer Immunotherapy Network for Canine Trials (PRECINCT) renewed for another five years
September 2022
The new Biomedical Data Science Seminar Series in PSOM is launched
September 2022
SEAS/PSOM Call for Proposals for Seed Funding in Trustworthy AI for Medicine
September 2022
2022 SEAS/PSOM Workshop Series on Trustworthy AI for Medicine
January 2022
New in JNCI: Pandemic not associated with treatment initiation delays for patients with advanced cancer
November 2021
2021 SEAS/PSOM Workshop on Trustworthy AI for Medicine
November 2021
New at NeurIPS 2021: Assessing Fairness in the Presence of Missing Data
November 2021
New in JAMA: Some Cancer Patients More Likely to Receive Immunotherapy, Despite Lack of Benefits
October 2021
New in PNAS: Minority collapse in deep learning, unfairness for minority groups in high-stakes decisionmaking
October 2021
Rebecca Hubbard Receives Jane M. Glick Graduate Student Teaching Award
September 2021
Rebecca Hubbard Appointed Statistical Editor at NEJM